Techh.info/biomedtechnology hourly

Cancer

headlines texts
25.11.2019
04:01 BBC HealthCancer survivors 'have higher heart risk'

More than 10% of patients in an extensive study died from cardiovascular disease - not their cancer.

Скрыть анонс
24.11.2019
21:22 News-Medical.NetUsing AI to determine which lung cancer patients will benefit from immunotherapy

Scientists from the Case Western Reserve University digital imaging lab, already pioneering the use of Artificial Intelligence to predict whether chemotherapy will be successful, can now determine which lung-cancer patients will benefit from expensive immunotherapy.

Скрыть анонс
10:43 News-Medical.NetNew tool uses tiny circuits made of DNA to identify cancer cells

A new cancer-detecting tool uses tiny circuits made of DNA to identify cancer cells by the molecular signatures on their surface.

Скрыть анонс
04:30 MedicalNewsToday.comMedical News Today: Anal cancer mortality rates have more than doubled in the US

Researchers warn that the incidence and mortality rates of anal cancer have been increasing steeply in the United States over a period of only 15 years.

Скрыть анонс
02:56 News-Medical.NetNew study provides better understanding of blood clot formation in cancer patients

Researchers have identified a potential new signaling pathway that may help further the understanding of blood clot formation in cancer patients and ultimately help prevent this complication from occurring.

Скрыть анонс
23.11.2019
06:19 Reuters.com HealthTakeda says cancer drug Alunbrig shows longer benefit vs. crizotinib

Japan's biggest drugmaker, Takeda Pharmaceutical Co Ltd, said long-term data show better outcomes for its Alunbrig drug in certain lung cancer patients compared to an existing treatment.

Скрыть анонс
04:16 BBC HealthCancer immunotherapy drug 'less toxic and prolongs life'

Pembrolizumab held advanced head and neck cancers in a group of patients at bay for around two years.

Скрыть анонс
01:12 MedicalNewsToday.comMedical News Today: Brain cancer: Lithium may restore cognitive function after radiation

New research has found that lithium improves memory and learning capabilities in young female mice that have undergone radiation treatment.

Скрыть анонс
00:27 CancerNetwork.comOncogene S100A10 May Play Role in Progression of Ovarian Cancer

Research suggests that oncogene S100A10 may play a definitive role in the progression of ovarian cancer and its expression levels may affect sensitivity to carboplatin.

Скрыть анонс
22.11.2019
23:48 News-Medical.NetBiosimilar for HER2+ breast cancer achieves similar overall response rate to reference drug

The trastuzumab biosimilar HLX02 achieved similar overall response rate to reference trastuzumab in women with human epidermal growth factor receptor 2-positive (HER2+) recurrent or previously untreated metastatic breast cancer, according to a large, randomized phase III study reported at the ESMO Asia 2019 Congress.

Скрыть анонс
21:37 CancerNetwork.comLess Frequent Surveillance Scan Policies Effective for Patients with Head and Neck Cancer

A new possible surveillance model suggests scanning patients with head and neck cancer treated with radiotherapy less frequently could be more cost-effective and time-effective.

Скрыть анонс
21:31 ScienceDaily.comTiny devices made of DNA detect cancer with fewer false alarms

A new cancer-detecting tool uses tiny circuits made of DNA to identify cancer cells by the molecular signature on their surface. The circuits work by attaching to the outside of a cell and analyzing it for proteins that are more abundant on some cell types than others. The devices distinguish cell types with higher specificity than previous methods, giving researchers hope their work could improve diagnosis, or give cancer therapies better aim.

Скрыть анонс
21:23 Phys.orgTiny devices made of DNA detect cancer with fewer false alarms

A new cancer-detecting tool uses tiny circuits made of DNA to identify cancer cells by the molecular signatures on their surface.

Скрыть анонс
20:59 Reuters.com HealthRoche says Tecentriq cocktail helps liver cancer patients live longer

Swiss drugmaker Roche on Friday said its immunotherapy Tecentriq combined with its Avastin medicine helped people with the most common form of liver cancer to live longer than with an older drug from Germany's Bayer.

Скрыть анонс
20:34 Reuters.com HealthRoche says Tecentriq cocktail boosts survival from liver cancer

Swiss drugmaker Roche on Friday said its immunotherapy Tecentriq combined with its Avastin medicine helped people with the most common form of liver cancer to live longer than with an older drug from Germany's Bayer.

Скрыть анонс
18:54 AzoNano.comNanoparticle Treatment Has Potential to Be Used as Rare Cancer Treatment

Image Credit: Crevis/Shutterstock.com Researchers exploring the use of nanoparticles to treat and reduce the size of deep-seated cancer cells have found their method to be effective. Using...

Скрыть анонс
18:37 Nature.ComA near-hopeless childhood cancer succumbs to drug duo

Скрыть анонс
18:15 Medscape.ComThe Week That Wasn't: Space Herpes, Hot Tea and Cancer, and Greedy Twins

Learn about herpes in space, the temperature at which hot tea may be linked to cancer, and why we need a #MeToo movement in the womb.

Скрыть анонс
17:39 FierceBiotech.comAzeria raises £32M to take breast cancer drug into humans

Azeria Therapeutics has raised £32 million ($41 million) to take its estrogen receptor positive breast cancer program into the clinic. The money will fund work on small molecule inhibitors of FOXA1, a pioneer factor involved in tumor development.

Скрыть анонс
16:00 News-Medical.NetPredicting opioid-related problems among cancer survivors

Opioids play an important role in how cancer patients manage pain, but the ongoing opioid epidemic has raised concerns about their potential for abuse.

Скрыть анонс
12:06 BBC HealthCancer: One in five cancer diagnoses 'in Emergency Departments'

Research shows that a quarter of bowel cancers and a third of lung cancer are diagnosed in this way.

Скрыть анонс
04:30 MedicalNewsToday.comMedical News Today: Colon cancer: Changes in gut bacteria may lead to new blood test

A new study conducted in mice and humans suggests that imbalances in gut bacteria may play a key role in the development of sporadic colorectal cancer.

Скрыть анонс
02:54 News-Medical.NetCancer patients more likely to die from stroke than general public

People living with or beyond cancer are more likely to die from stroke than the general public, according to new Penn State research, and certain types of cancer may boost the risk even more.

Скрыть анонс
02:19 Reuters.com HealthDiets with more fiber, yogurt tied to lower risk of lung cancer

(Reuters Health) – Even among smokers, people who eat more fiber and yogurt may be less likely to develop lung cancer than those who don't consume much of these foods, a research review suggests.

Скрыть анонс
21.11.2019
22:51 News-Medical.NetExtra DNA scooped up alongside cancer-causing genes helps drive cancer growth

One of the ways a cancer-causing gene works up enough power to turn a normal cell into a cancer cell is by copying itself over and over, like a Xerox machine.

Скрыть анонс
22:27 CancerNetwork.comSex Disparity in Recurrence Score Among Patients with Early Stage ER-Positive Breast Cancer

Oncotype DX® Breast Recurrence Scores from the National Cancer Database indicated that a lower threshold is needed for male patients with early stage ER-positive breast cancer to predict mortality.

Скрыть анонс
21:57 News-Medical.NetResearchers design new antitumoral drug release strategy for breast cancer treatment

The local release of antitumoral drugs through bacterial proteins in the treatment of breast cancer can mark a before and after in precision medicine.

Скрыть анонс
21:45 News-Medical.NetUIC receives $1.8 million CDC grant for new breast cancer survivorship research

With $1.8 million in funding from the U.S. Centers for Disease Control and Prevention, the University of Illinois at Chicago will help young breast cancer survivors navigate post-treatment care and survival.

Скрыть анонс
21:08 News-Medical.NetStudy could help predict resistance to pancreatic cancer treatments

A study from the University of North Carolina Lineberger Comprehensive Cancer Center could help predict resistance to treatments for pancreatic cancer, one of the deadliest cancer types.

Скрыть анонс
20:30 Medscape.ComAge No Excuse Not to Treat Lung Cancer, Even in 'Oldest Old'

Many lung cancer patients aged 90 years or older are not offered treatment for lung cancer, but they can do well, especially after surgery for earlier-stage disease.

Скрыть анонс
19:02 News-Medical.NetStatin use may reduce risk of developing lethal prostate cancer

New research led by Queen's University Belfast has found that men who are on statins, medicine used to lower blood cholesterol, may have a reduced risk of developing a more lethal form of prostate cancer.

Скрыть анонс
16:19 FierceBiotech.comCould this ring-shaped DNA change how we treat cancer?

A team led by scientists at the University of California, San Diego and Stanford University suggests a type of doughnut-shaped DNA outside the chromosome gives cancer cells their malignant qualities, promoting the expression of cancer-driving oncogenes and helping tumors evolve and resist treatments.

Скрыть анонс
14:47 News-Medical.NetNationwide survey highlights patients’ perspectives about cancer treatment experiences

One in three adults treated for cancer may experience side effects from treatment they wish they had known more about, according to a new survey published today in the Journal of Oncology Practice.

Скрыть анонс
13:30 Technology.orgWidower’s search for cancer cure takes surprising turn

When his wife died of a rare ovarian cancer 10 years ago, Powel Crosley vowed to find a

Скрыть анонс
10:46 Technology.orgArthritis drugs could be repurposed to help prevent breast cancer spreading to the bone, study suggests

Drugs commonly used to treat arthritis may help to prevent breast cancer spreading to the bone, where it

Скрыть анонс
00:29 CancerNetwork.comPhase III HERO Study Meets Primary Efficacy Endpoint in Men with Advanced Prostate Cancer

Myovant announced that their phase III HERO study of relugolix met its primary efficacy end point and all 6 secondary endpoints in men with advanced prostate cancer.

Скрыть анонс
00:03 LiveScience.com'Doughnut-Shaped' DNA Makes Cancer More Aggressive

"DNA conveys information not only in its sequence but also in its shape," the authors said.

Скрыть анонс
20.11.2019
23:45 ScienceDaily.comVicious circles: Ring-shaped DNA provides cancer cells with a malignant twist

Researchers describe how circular extrachromosomal DNA in cancer cells boosts aggressiveness and resistance to therapies.

Скрыть анонс
21:35 Drugs.comHPV Blamed for Rising Rates of Anal Cancer

WEDNESDAY, Nov. 20, 2019 -- Anal cancer rates have surged in the past 15 years, and the sexually transmitted human papillomavirus (HPV) may be to blame, a new study suggests. "What was very shocking to us was that the rate and incidence of anal...

Скрыть анонс
21:20 NYT ScienceScientists Are Just Beginning to Understand Mysterious DNA Circles Common in Cancer Cells

For years, researchers weren’t exactly sure what to make of these extra loops of genetic material . That’s quickly changing.

Скрыть анонс
20:44 TechnologyReview.comA giant, superfast AI chip is being used to find better cancer drugs

A new generation of specialized hardware could make drug development and material discovery orders of magnitude faster.

Скрыть анонс
17:47 News-Medical.NetAtlantic Health System offers advanced lung cancer screening program

November is national Lung Cancer Awareness Month. Lung cancer remains the #1 cancer killer of both men and women in the United States.

Скрыть анонс
15:41 Reuters.com HealthBristol-Myers misses main goal of late-stage skin cancer trial

Bristol-Myers Squibb Co said on Wednesday its late-stage trial testing a combination of its cancer drugs missed a main goal of preventing skin cancer from recurring in a certain group of patients.

Скрыть анонс
15:01 News-Medical.NetStudy shows gender differences in prognosis predictive utility of breast cancer recurrence score

The TAILORx study published last year offered good news for women with early-stage ER-positive breast cancer who scored at intermediate risk for recurrence according to a genetic assay test.

Скрыть анонс
10:44 Technology.orgThinking Small. PNNL Focuses on Tiny Particles to Fight Global Problems Like Cancer

Researchers at the Department of Energy’s Pacific Northwest National Laboratory are developing tiny solutions for some of today’s

Скрыть анонс
03:34 CNN HealthAnal cancer rates and deaths are climbing in the US, study says

Anal cancer cases and deaths are rising dramatically in the United States, especially among older people and young black men, a new study says.

Скрыть анонс
02:23 News-Medical.NetCell factors decide if a cancer grows or dies, says new study

A new study published today in the journal Cell Reports by scientists at the German Cancer Research Center (DKFZ) shows that the direction taken by a cancer cell depends on the configuration of the cell itself as well as the activation of a universal cancer cell receptor called CD95.

Скрыть анонс
02:18 Nature.ComPublisher Correction: Harnessing innate immunity in cancer therapy

Nature is the international weekly journal of science: a magazine style journal that publishes full-length research papers in all disciplines of science, as well as News and Views, reviews, news, features, commentaries, web focuses and more, covering all branches of science and how science impacts upon all aspects of society and life.

Скрыть анонс
00:55 News-Medical.NetWoman’s velvety tripe palms turn out to be a sign of lung cancer

A 73-year-old woman presented with pruritic, itchy, and painful lesions on her hand, showing an appearance consisted of tripe palms. It was later revealed by doctors that her velvety palms turned out to be a rare sign of lung cancer.

Скрыть анонс
00:53 News-Medical.NetImproving the efficiency of antiangiogenic and antifibrotic drug for treatment of lung cancer

The University of Barcelona and Hospital Clínic de Barcelona collaborate with Boehringer Ingelheim Inc. to improve the efficiency of nintedanib, an antiangiogenic and antifibrotic drug, for the treatment of lung cancer.

Скрыть анонс
19.11.2019
23:55 CancerNetwork.comKathryn Arbour, MD, on the Development of KRAS G12C Inhibitors in Lung Cancer

The MSK expert discusses exciting advancements in the field of immunotherapy for treating lung cancer at the Annual New York Lung Cancers Symposium®.

Скрыть анонс
23:17 News-Medical.NetPatients treated at NCI-designated centers more likely to receive high-cost lung cancer drugs

Genetically targeted drugs and immunotherapies are transforming the way we treat many forms of lung cancer.

Скрыть анонс
21:46 News-Medical.Net25 years of research to fight cervical cancer

According to the World Health Organization, cervical cancer is the fourth most common type of cancer affecting women worldwide. Currently, early screenings of pre-cancerous tissues and vaccination have proven to be the most effective treatment strategies.

Скрыть анонс
20:46 News-Medical.NetProstate cancer patients receiving care at MultiD clinic more likely to be advised about treatment choices

Newly diagnosed prostate cancer patients have multiple standard-of-care treatment options available, but many are not fully informed of their choices.

Скрыть анонс
20:11 CancerNetwork.comOpioid Use in Prostate Cancer Clinical Trials Appears to Vary by World Region

An international study of prostate cancer clinical trials discovered that opioid use appears to differ by region, implying that a variability should be considered.

Скрыть анонс
19:58 StemCellsPortal.comlNew Biomarker Found for Cancer Stem Cells

HOUSTON, TX (US), November 2019 — In the world of cancer biology, not all biomarkers are created equal. These molecules that alert doctors that an abnormal process may be under way can appear as an array of aberrant proteins, such as hormones, enzymes or signaling molecules, and vary from patient to patient. Because they are a mixed bag, no one drug exists to attack them.
But now, a University of Houston College of Pharmacy associate professor has discovered a new biomarker in cancer stem cells that govern cancer survival and spread, and it's raising hope that drug discovery to kill cancer stem cells could follow suit.
"We have found a new biomarker, the protein plectin, on cancer stem cells. We believe plectin may be a more common biomarker that could lead to broadly applicable drug development," reported Gomika Udugamasooriya, Ph.D., in Nature Scientific Reports. "Plectin is a

Скрыть анонс
19:55 News-Medical.NetAnal cancer diagnoses and death rates have increased dramatically over the last 15 years

Rates of new anal cancer diagnoses and deaths related to human papillomavirus, the most common sexually transmitted infection, have increased dramatically over the last 15 years, according to researchers at The University of Texas Health Science Center at Houston.

Скрыть анонс
18:49 ScienceDaily.comNew screening method identifies inhibitors of cancer cell metabolism

A new screening system developed by scientists leverages redundancy in an important component of a cell - nucleotide metabolism - to help identify new drugs that specifically and potently block processes that are essential for cancer cell growth.

Скрыть анонс
17:42 Geek.comAstronaut Training Routine May Help Cancer Patients

The ways astronauts prep for spaceflight could benefit cancer patients (via Memorial Sloan Kettering Cancer Center) Being an astronaut isn’t always as glamorous as it seems: During spaceflight, folks experience physical stress similar to that of cancer patients undergoing treatment. So perhaps by mimicking a NASA cosmonaut’s exercise regimen […]
The post Astronaut Training Routine May Help Cancer Patients appeared first on Geek.com.

Скрыть анонс
17:26 News-Medical.NetRutgers Cancer Institute researchers awarded $2.3 million in American Cancer Society grants

More than $2.3 million in Research Scholar Grants from the American Cancer Society have been awarded to three Rutgers Cancer Institute of New Jersey researchers to examine cell metabolism and tumor formation in forms of breast cancer, lung cancer and leukemia.

Скрыть анонс
16:51 FierceBiotech.comMyovant's oral prostate cancer drug matches incumbent in phase 3

A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval next year. 

Скрыть анонс
16:19 ScienceDaily.comGut microbiota imbalance promotes the onset of colorectal cancer

Researchers have demonstrated that an imbalance in the gut microbiota, also known as 'dysbiosis', promotes the onset of colorectal cancer. The teams demonstrated that transplanting fecal flora from patients with colon cancer into mice caused lesions and epigenetic changes characteristic of the development of a malignant tumor. The pilot study led to the development of a non-invasive blood test which identifies the epigenetic phenomenon associated with dysbiosis. The test was validated in 1,000 individuals.

Скрыть анонс
15:21 Phys.orgA computer model has learned to detect prostate cancer

Scientists at the TSU Laboratory of Biophotonics, working with Tomsk National Research Medical Center (TNIMC) oncologists, have developed a new approach to the diagnosis of adenocarcinoma, a malignant tumor of the prostate gland, that uses artificial intelligence to identify oncopathology and determine the stage of the disease. Using machine learning, a computer model was taught to distinguish between healthy tissues and pathology with 100 percent accuracy.

Скрыть анонс
12:32 ClinicalOncology.comCenter Works With Payor to Toss Cancer Imaging PAs

San Diego—Cancer care providers can partner with commercial payors to eliminate some prior authorizations, potentially reducing time to treatment and anxiety for patients, and administrative burdens for physicians, according to a study presented at the American Society of Clinical Oncology 2019 Quality Care Symposium.

Скрыть анонс
12:04 News-Medical.NetSurgery can improve survival rate for oldest patients with early stage lung cancer

Many patients with early stage lung cancer who are age 90 years and older do not receive treatment; however, surgery in this nonagenarian population should be considered because it could significantly increase the chances for 5-year survival, according to research published online today in The Annals of Thoracic Surgery.

Скрыть анонс
11:26 BBC HealthOllie Gardiner: Cancer teen's family donates treatment funds to research

Ollie Gardiner's family raised money to treat his brain tumour but he died aged 13 after a relapse.

Скрыть анонс
10:48 News-Medical.NetRadiation from CT scans can increase risk of leukemia, thyroid cancer

A new study in JNCI Cancer Spectrum finds that exposure to radiation from CT scans is associated with higher risks of developing thyroid cancer and leukemia.

Скрыть анонс
02:30 News-Medical.NetNew drug combo may improve pancreatic cancer therapy

A new study by scientists at Sanford Burnham Prebys Medical Discovery Institute have discovered a combination of two cancer-fighting drugs that successfully worked on pancreatic tumor in mice, shrinking them significantly, and paving the way for a speedy clinical trial designed to test their efficacy in humans.

Скрыть анонс
00:04 News-Medical.NetNeural architecture search automates the development of deep learning-based models for cancer research

Argonne researchers have created a neural architecture search that automates the development of deep-learning-based predictive models for cancer data.

Скрыть анонс
18.11.2019
23:55 CancerNetwork.comNew Clinical Trial Aims to Reduce Malnutrition Among Patients with Lung Cancer

Four cancer centers are joining forces on a new clinical trial designed to test medically tailored meals for patients with lung cancer to combat malnutrition.

Скрыть анонс
23:39 News-Medical.NetCancer drug shows promise in treating metabolic syndrome

Metabolic syndrome is a group of health problems characterized by the presence of elevated blood pressure, increased levels of triglycerides, high blood sugar, excess body fat around the waist, and obesity. If it’s left untreated, it can increase the risk of heart disease, stroke, and type 2 diabetes. Usually, treating metabolic syndrome involves targeting individual risk factors and modifying lifestyle practices.

Скрыть анонс
22:01 Drugs.comExpert: Herbal Aids Can Cause Harm When Breast Cancer Spread to Skin

MONDAY, Nov. 18, 2019 -- Using herbal products to treat breast cancer that's spread to the skin could slow wound healing and interfere with chemotherapy or hormone treatment, an expert warns. Many patients try herbal products and creams to treat...

Скрыть анонс
21:06 News-Medical.Net'Dysbiosis' promotes the onset of colorectal cancer

The gastroenterology team at Henri-Mondor AP-HP Hospital and University Paris-Est Créteil, led by Professor Iradj Sobhani, together with teams from Inserm and the Institut Pasteur Molecular Microbial Pathogenesis Unit (U1202), led by Professor Philippe Sansonetti - holder of the Microbiology and Infectious Diseases Chair at the Collège de France -, have demonstrated that an imbalance in the gut microbiota, also known as "dysbiosis", promotes the onset of colorectal cancer.

Скрыть анонс
19:53 Reuters.com HealthPortuguese foundation launches world's largest cancer award

Portugal's Champalimaud Foundation announced on Monday the world's largest annual prize, worth 1 million euros, for research and clinical practices aiming to control or eradicate cancer.

Скрыть анонс
18:50 CancerNetwork.comFergus Couch, PhD, on the CARRIERS Studies in Breast Cancer

Fergus Couch, PhD, from the Mayo Clinic, discusses with CancerNetwork about the new research with the CARRIERS study for African American patients with breast cancer.

Скрыть анонс
16:24 ScienceDaily.comOmega-3 shows protection against heart disease-related death, without prostate cancer risk

A research team identified 87 patients who were part of the Intermountain INSPIRE Registry and had developed prostate cancer. These patients were also tested for plasma levels of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), which are two common omega-3 fatty acids.

Скрыть анонс
15:39 Phys.orgNew insight into a cancer-shielding protein could guide a new generation of cancer treatments

In a paper published in Cell Reports, a team of researchers from the Department of Energy's SLAC National Accelerator Laboratory and Stanford University discovered unique characteristics of a protein called VISTA that protects cancer cells against immune system strikes. A better understanding of how this protein works could guide the design of treatments that target these proteins, infiltrating cancer's first line of defense.

Скрыть анонс
10:26 News-Medical.NetStudy explores the overall rate of new cancer cases in Canada from 1971 to 2015

The overall rate of new cancer cases is decreasing in men but increasing in women younger than 80 years, and obesity-related cancers are increasing in young people, according to a study on cancer trends in Canada from 1971 to 2015 published in CMAJ (Canadian Medical Association).

Скрыть анонс
06:00 BBC HealthNHS staff shortages put 'cancer survival rates at risk'

A Holyrood committee finds 18% of cancer patients in June were not seen within the six-week target.

Скрыть анонс
05:49 News-Medical.NetOmega-3 supplement continues to protect heart health without increasing prostate cancer risk

Should you take omega-3 pills? Or try to have two to servings of omega-3 rich fish a week, as the American Heart Association recommends? It may seem a bit murky if you follow headlines about nutrition and health.

Скрыть анонс
17.11.2019
16:45 News-Medical.NetUCLA Health pulmonologist describes the signs and symptoms of lung cancer

Nikki Moreno, a 42-year-old mother of two, was not expecting to hear she had advanced lung cancer when she ended up in the emergency room at the UCLA Medical Center, Santa Monica, last October. She hadn't been feeling well for over a year but didn't think too much of her symptoms.

Скрыть анонс
16.11.2019
04:32 MedicalNewsToday.comMedical News Today: Late stage breast cancer survival estimate is 'rarely accurate'

Single-number survival estimates for people with late stage breast cancer are unhelpful, research shows. So what approach would be more beneficial?

Скрыть анонс
15.11.2019
23:41 CancerNetwork.comLower Prostate Cancer Risk in Men with Diabetes May Be Due to Detection Bias

Fewer biopsies among men receiving antidiabetic medications may explain the lower prostate cancer risk in men with diabetes.

Скрыть анонс
22:08 Nanowerk.comNewly developed nanoparticles help fight lung cancer in animal model

Scientists have reported a new approach to treating lung cancer with inhaled nanoparticles.

Скрыть анонс
21:39 News-Medical.NetFor cancer screening, nudges need to be directed to both clinicians and patients

When the electronic health record is programmed to automatically flag and create orders for patients needing cancer screenings, doctors are significantly more likely to order them, a new Penn Medicine study shows. However, the study showed that the other part of the equation -- patients following through on those screenings -- was unaffected by the increase in orders.

Скрыть анонс
20:31 Medscape.ComLung Cancer Progress: Survival Increasing in US

More people are now alive 5 years after being diagnosed with lung cancer than a decade ago, but the incidence of and mortality from lung cancer varies widely across the United States.

Скрыть анонс
20:03 News-Medical.NetMining 'darkest' parts of the genome in cancer cells yields gold

Mining the rich uncharted territory of the genome or genetic material of a cancer cell has yielded gold for Princess Margaret scientists: new protein targets for drug development against prostate cancer.

Скрыть анонс
19:37 Reuters.com HealthWomen in prison have higher rates of HPV, cervical cancer

(Reuters Health) - Across the world, imprisoned women have higher rates of cervical cancer and the human papillomavirus (HPV) infection that can lead to cancer, according to a research review.

Скрыть анонс
18:57 AzoNano.comNew Approach to Treating Lung Cancer with Inhaled Nanoparticles

A new technique for treating lung cancer by inhaling nanoparticles created at Wake Forest School of Medicine, part of Wake Forest Baptist Health, has been reported by researchers. As part of the...

Скрыть анонс
17:23 CancerNetwork.comAdverse Events To Be Aware of With Immunotherapy Treatment in Lung Cancer

Beth Eaby-Sandy, a nurse practitioner, discussed AEs associated with immunotherapy treatment in patients with lung cancer.

Скрыть анонс
17:16 ScienceDaily.comA step closer to cancer precision medicine

Researchers have developed a computational model, Combined Essentiality Scoring (CES), that enables accurate identification of essential genes in cancer cells for development of anti-cancer drugs.

Скрыть анонс
17:09 FierceBiotech.comEpicentRx raises $35M to fund late-phase lung cancer trial

EpicentRx has raised $35 million for late-phase development of RRx-001. The biotech began testing the small molecule in a phase 3 trial of heavily pretreated small cell lung cancer patients late last year. 

Скрыть анонс
16:04 News-Medical.NetShared care model for early follow-up of breast cancer survivors

Survivors of early breast cancer will take part in a new nationwide study trialing a shared care model between cancer specialists and GPs for the follow-up care when they have completed their initial treatment.

Скрыть анонс
14:56 ScientificAmerican.ComPlasma Scalpel Takes On Cancer

A pilot study is ongoing with the new tool -- Read more on ScientificAmerican.com

Скрыть анонс
13:29 Technology.orgEliminating Common Bacterial Infection Significantly Decreases Gastric Cancer Risk

While it is well known within the medical community that there is a link between the bacteria Helicobacter

Скрыть анонс
12:25 Technology.orgResearchers Halt Spread of Breast Cancer by Blocking Metastasis-Promoting Enzyme

In a breakthrough with important implications for the future of immunotherapy for breast cancer, UC San Francisco scientists

Скрыть анонс
03:26 News-Medical.NetResearch explains why immunotherapy fails against prostate cancer bone metastases

Prostate cancer that spreads to the bone triggers the destruction of bone tissue that, in turn, thwarts the effectiveness of immune checkpoint inhibitors by blocking the development of T cells that are crucial to successful treatment, researchers from The University of Texas MD Anderson Cancer Center report in Cell.

Скрыть анонс
00:42 News-Medical.NetLithium corrects radiation damage to brain in young cancer patients

A new study on mice, published online in the journal Molecular Psychiatry, on November 14, 2019, shows that the intermittent use of lithium, which is widely used to stabilize the mood in conditions such as bipolar disorder, can correct memory and learning losses due to radiation therapy to the brain in very young animals, even when the lithium is given long after the injury.

Скрыть анонс
14.11.2019
23:30 Reuters.com HealthCancer doctors hesitate to discuss fertility issues with young women

(Reuters Health) - Although cancer doctors know it's important to talk about fertility concerns with young women patients, they may feel uncomfortable and unprepared to discuss the issue, a study in Canada suggests.

Скрыть анонс
23:18 News-Medical.NetInhaled nanoparticles can help treat lung cancer

Scientists have reported a new approach to treating lung cancer with inhaled nanoparticles developed at Wake Forest School of Medicine, part of Wake Forest Baptist Health.

Скрыть анонс